Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, S. Y. | - |
dc.contributor.author | Lee, J. S. | - |
dc.contributor.author | Son, J. S. | - |
dc.contributor.author | Ko, J. H. | - |
dc.contributor.author | Peck, K. R. | - |
dc.contributor.author | Jung, Y. | - |
dc.contributor.author | Woo, H. J. | - |
dc.contributor.author | Joo, Y. S. | - |
dc.contributor.author | Eom, J. S. | - |
dc.contributor.author | Shi, H. | - |
dc.date.available | 2020-02-27T04:42:58Z | - |
dc.date.created | 2020-02-05 | - |
dc.date.issued | 2019-01 | - |
dc.identifier.issn | 0195-6701 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/2020 | - |
dc.description.abstract | An effective post-exposure prophylaxis (PEP) strategy may limit the spread of infection. However, there is no consensus regarding PEP for Middle East respiratory syndrome coronavirus (MERS-CoV) infection. This study assessed the efficacy of ribavirin and lopinavir/ritonavir as PEP for healthcare workers (HCWs) exposed to patients with severe MERS-CoV pre-isolation pneumonia. The safety of the PEP regimen was assessed. HCWs with high-risk exposure to MERS-CoV pre-isolation pneumonia were retrospectively enrolled. HCWs who received PEP therapy were classified into the PEP group. PEP therapy was associated with a 40% decrease in the risk of infection. There were no severe adverse events during PEP therapy. (C) 2018 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | W B SAUNDERS CO LTD | - |
dc.relation.isPartOf | JOURNAL OF HOSPITAL INFECTION | - |
dc.title | Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000456379900007 | - |
dc.identifier.doi | 10.1016/j.jhin.2018.09.005 | - |
dc.identifier.bibliographicCitation | JOURNAL OF HOSPITAL INFECTION, v.101, no.1, pp.42 - 46 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85056156511 | - |
dc.citation.endPage | 46 | - |
dc.citation.startPage | 42 | - |
dc.citation.title | JOURNAL OF HOSPITAL INFECTION | - |
dc.citation.volume | 101 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Eom, J. S. | - |
dc.contributor.affiliatedAuthor | Shi, H. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Post-exposure prophylaxis | - |
dc.subject.keywordAuthor | Middle East respiratory syndrome coronavirus | - |
dc.subject.keywordAuthor | Outbreak | - |
dc.subject.keywordAuthor | Healthcare worker | - |
dc.subject.keywordAuthor | High-risk exposure | - |
dc.subject.keywordAuthor | Pre-isolation pneumonia | - |
dc.subject.keywordPlus | SYNDROME CORONAVIRUS INFECTION | - |
dc.relation.journalResearchArea | Public, Environmental & Occupational Health | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Public, Environmental & Occupational Health | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.